This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effec ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

The FDA has accepted for review the New Drug Application for plozasiran for the treatment for familial chylomicronemia syndrome.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

In a marquee rematch against the Oilers, the Canucks didn't start to find their legs until they were down by five goals.

"Fight-or-flight" is not an option for plants, unfortunately, when it comes to pathogen attacks. Instead, plants opt for ...

Researchers at the Technion-Israel Institute of Technology have discovered a unique genetic mechanism that provides cells with rapid and efficient protection against viruses. The findings could lead ...